 |
|
The Impact of Continuous Positive Airway Pressure on Blood Pressure in Patients With Obstructive Sleep Apnea SyndromeEvidence From a Meta-analysis of Placebo-Controlled Randomized Trials
Patrick Haentjens, MD, PhD;
Alain Van Meerhaeghe, MD;
Antonio Moscariello, MD;
Sonia De Weerdt, MD;
Kris Poppe, MD, PhD;
Alain Dupont, MD, PhD;
Brigitte Velkeniers, MD, PhD
Arch Intern Med. 2007;167(8):757-764.
Background Continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea syndrome (OSAS) might lower blood pressure, but evidence from clinical studies is inconsistent, perhaps as a result of small sample size or heterogeneity in study design. This study aimed to assess whether CPAP reduces ambulatory blood pressure in patients with OSAS, to quantify the effect size with precision, and to identify trial characteristics associated with the greatest blood pressure reductions.
Methods We identified randomized controlled trials of CPAP vs placebo in patients with OSAS specifically reporting 24-hour ambulatory mean blood pressure (MBP).
Results We included a total of 572 patients from 12 randomized controlled trials. According to a random-effects model, the pooled estimate of the effect of the CPAP intervention was a net decrease of 1.69 mm Hg in 24-hour MBP (95% confidence interval, –2.69 to –0.69). Statistical heterogeneity was moderate (I2 = 41%). Predefined metaregression analyses estimated that 24-hour MBP would decrease by 0.89 mm Hg per 10-point increase in apnea-hypopnea index at entry (P = .006), by 0.74 mm Hg for each increase of 10 arousal events per hour slept (P = .008), and by 1.39 mm Hg for each 1-hour increase in effective nightly use of the CPAP device (P = .01).
Conclusions Among patients with OSAS, CPAP reduces 24-hour ambulatory MBP, with greater treatment-related reductions in ambulatory MBP among patients with a more severe degree of OSAS and a better effective nightly use of the CPAP device. These reductions in blood pressure are likely to contribute to a better prognosis in terms of adverse cardiovascular events.
Author Affiliations: Center for Outcomes Research and Laboratory for Experimental Surgery (Dr Haentjens) and Departments of Pneumology (Dr De Weerdt), Endocrinology (Drs Poppe and Velkeniers), Pharmacology (Dr Dupont), and General Internal Medicine (Drs Poppe and Velkeniers), Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium; and Service de Pneumologie, Intercommunale de Santé Publique du Pays de Charleroi, Centre Hospitalier Universitaire André Vésale, Montigny-le-Tilleul, Belgium (Drs Van Meerhaeghe and Moscariello).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Adherence to Sleep Apnea Therapy and Use of Lipid-Lowering Drugs: A Study of the Healthy-User Effect
Platt et al.
Chest 2010;137:102-108.
ABSTRACT
| FULL TEXT
From the author:
Levy
Eur Respir J 2009;34:1210-1211.
FULL TEXT
Continuous Positive Airway Pressure Treatment Reduces Mortality in Patients with Ischemic Stroke and Obstructive Sleep Apnea: A 5-Year Follow-up Study
Martinez-Garcia et al.
Am. J. Respir. Crit. Care Med. 2009;180:36-41.
ABSTRACT
| FULL TEXT
Sleep and the Cardiovascular System
Yaggi
ACCP Sleep Med Brd Rev 2009;4:123-132.
FULL TEXT
Positive Airway Pressure Therapy for Obstructive Sleep Apnea Syndrome: The Boards and Beyond
Freedman
ACCP Sleep Med Brd Rev 2009;4:293-312.
FULL TEXT
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
Levy et al.
Eur Respir J 2008;32:1082-1095.
ABSTRACT
| FULL TEXT
Metabolic Syndrome, Obstructive Sleep Apnea, and Continuous Positive Airway Pressure: A Weighty Issue
Yeh et al.
Chest 2008;134:675-676.
FULL TEXT
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Somers et al.
Circulation 2008;118:1080-1111.
FULL TEXT
Cardiorespiratory Fitness and Obstructive Sleep Apnea Syndrome in Morbidly Obese Patients
Vanhecke et al.
Chest 2008;134:539-545.
ABSTRACT
| FULL TEXT
Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health)
Somers et al.
J Am Coll Cardiol 2008;52:686-717.
FULL TEXT
Sleep Apnea and Hypertension: Interactions and Implications for Management
Kapa et al.
Hypertension 2008;51:605-608.
FULL TEXT
Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application
Sanders et al.
Proc Am Thorac Soc 2008;5:161-172.
ABSTRACT
| FULL TEXT
Obstructive Sleep Apnea, Cardiovascular Disease, and Pulmonary Hypertension
Golbin et al.
Proc Am Thorac Soc 2008;5:200-206.
ABSTRACT
| FULL TEXT
Obstructive Sleep Apnea and Resistant Hypertension: A Case-Control Study
Goncalves et al.
Chest 2007;132:1858-1862.
ABSTRACT
| FULL TEXT
Treating Obstructive Sleep Apnea: Is There More to the Story Than 2 Millimeters of Mercury?
Floras and Bradley
Hypertension 2007;50:289-291.
FULL TEXT
Does CPAP Lower Blood Pressure in Patients with Sleep Apnea?
JWatch General 2007;2007:2-2.
FULL TEXT
|
